Intravenous Versus Intraarterial Transplantation of Human Umbilical Cord Blood Mononuclear Cells for Brain Ischemia in Rats

Cerebral ischemia is among the most common type of stroke seen in patient. Regeneration of death neurons remains questionable. Human umbilical cord blood mononuclear cell(cbMNC) is one of the treatment options for ischemia stroke through their various advantages; availability, pluripotency, and imma...

Full description

Saved in:
Bibliographic Details
Main Authors: Ramli, Yetty (Author), Alwahdy, Ahmad Sulaiman (Author), Kurniawan, Mohammad (Author), Juliandi, Berry (Author), Wuyung, Puspita Eka (Author), Susanto, Yayi Dwina Bilianti (Author)
Format: EJournal Article
Published: Bogor Agricultural University, Indonesia, 2018-03-27.
Subjects:
Online Access:Get fulltext
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02504 am a22003373u 4500
001 HAYATI_20827_14268
042 |a dc 
100 1 0 |a Ramli, Yetty  |e author 
700 1 0 |a Alwahdy, Ahmad Sulaiman  |e author 
700 1 0 |a Kurniawan, Mohammad  |e author 
700 1 0 |a Juliandi, Berry  |e author 
700 1 0 |a Wuyung, Puspita Eka  |e author 
700 1 0 |a Susanto, Yayi Dwina Bilianti  |e author 
245 0 0 |a Intravenous Versus Intraarterial Transplantation of Human Umbilical Cord Blood Mononuclear Cells for Brain Ischemia in Rats 
260 |b Bogor Agricultural University, Indonesia,   |c 2018-03-27. 
500 |a https://journal.ipb.ac.id/index.php/hayati/article/view/20827 
520 |a Cerebral ischemia is among the most common type of stroke seen in patient. Regeneration of death neurons remains questionable. Human umbilical cord blood mononuclear cell(cbMNC) is one of the treatment options for ischemia stroke through their various advantages; availability, pluripotency, and immaturity. One group of healthy rats and three groups (n = 6 per group) of male Wistar rats undergone permanent middle cerebral artery occlusion (MCAO). Rats were allowed to recover for 7 days before intraarterial and intravenous injection of 1 × 106 cells/kg of human cbMNC. Behavioral tests were performed before the MCAO, 1 week after MCAO, and at 3, 9, and 14 days after cbMNC injection. Brain infarct area and neurons in hippocampus were evaluated. Spontaneous activity was much significantly improved compared with the placebo group (p < 0.05). Comparing the neuron cells in hippocampus, intraarterial and intravenous have more changes in neurons morphology. No effect of cbMNC implantation in decreasing infarct area. Safety of xenogenic was confirmed by this study when the dosage of 1 × 106 cells/kg was used and showed their beneficial effects. 
546 |a eng 
690 |a human umbilical cord blood 
690 |a middle cerebral artery occlusion 
690 |a monofilament 
690 |a mononuclear cells 
690 |a rats 
655 7 |a info:eu-repo/semantics/article  |2 local 
655 7 |a info:eu-repo/semantics/publishedVersion  |2 local 
655 7 |a Peer-reviewed Article  |2 local 
786 0 |n HAYATI Journal of Biosciences; Vol. 24 No. 4 (2017): October 2017; 187 
786 0 |n 2086-4094 
786 0 |n 1978-3019 
787 0 |n https://journal.ipb.ac.id/index.php/hayati/article/view/20827/14268 
856 4 1 |u https://journal.ipb.ac.id/index.php/hayati/article/view/20827/14268  |z Get fulltext